Remdesivir Versus Sotrovimab in Coronavirus Disease 2019: A Systematic Review and Meta‐Analysis
ABSTRACT Background and Aim Remdesivir and Sotrovimab have emerged as potential treatment options for patients diagnosed with coronavirus disease 2019 (COVID‐19). This systematic review and meta‐analysis sought to evaluate and compare the effectiveness and safety of these two drugs in the context of...
Saved in:
| Main Authors: | Saeed Khorramnia, Zia Navidi, Ali Sarkoohi, Mojgan Mohajeri Iravani, Amirhossein Orandi, Amirali Orandi, Samrand Fattah Ghazi, Ehsan Fallah, Ebadallah Shiri Malekabad, Seyed Hamid Pakzad Moghadam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Health Science Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/hsr2.71118 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcome of COVID-19 and tolerance of Remdesivir in patients with renal failure: a single center experience from Pakistan
by: Zaheer Udin Babar, et al.
Published: (2023-06-01) -
Selective six spectrophotometric methods for determination of remdesivir and moxifloxacin hydrochloride for COVID-19 treatment with overlapping spectra: a comprehensive evaluation of greenness, blueness, and whiteness
by: Eman A. Madbouly, et al.
Published: (2025-08-01) -
Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated
by: Delma J. Nieves, et al.
Published: (2025-03-01) -
Remdesivir and hospitalization outcomes in patients with COVID -19 in the period of SARS-CoV-2 Delta circulation
by: D. V. Litvinchuk, et al.
Published: (2025-06-01) -
Is There Enough Evidence to Avoid Remdesivir Use in Patients with Severe Renal Impairment? A Review of the Pharmacological and Clinical Literature
by: Suresh J. ANTONY, et al.
Published: (2021-12-01)